← board
AIBT
distress 7/10 · high distress / dilution risk$0.000%today-90% from 52w high
Revenue
pre-revenue
Liquidity
$0M
Runway
0.6 yrs
Shares 1y
+255%
Price & events
-50.0% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
+0.0%
1W
+0.0%
1M
+0.0%
3M
-50.0%
6M
-83.3%
1Y
-97.5%
2Y
-99.9%
5Y
-99.9%
All
Overview
- Market Cap
- $681.99K
- Volume
- 34.25M
- 52 Week Range
- $0.00 – $0.01
- Total Shares
- 681.99M
- Float Shares
- 565.93M
- % Held by Insiders
- 17.02%
- % Held by Institutions
- 0.00%
- RVOL
- 4.24x
- Beta
- 1.28
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.